Sökning: "upper respiratory tract infections"
Visar resultat 1 - 5 av 37 avhandlingar innehållade orden upper respiratory tract infections.
1. Mucosal immunity in the respiratory tract : The role of IgA in protection against intracellular pathogens
Sammanfattning : The lungs and upper airways are mucosal surfaces that are common site for infection with an enormous variety of inhaled pathogens. Therefore, induction of immune responses in the respiratory tract is crucial for protection against respiratory diseases. One of the pathogens infecting the host via the respiratory tract is Mycobacterium Tuberculosis. LÄS MER
2. Viral respiratory tract infections in children
Sammanfattning : The most common infection in humans is viral respiratory tract infections which predominantly present as the ‘common cold’. In some circumstances however, respiratory viruses cause acute lower respiratory tract infections (RTIs) and due to the high absolute number of infection the contribution of these cases to total morbidity and mortality are substantial. LÄS MER
3. On the Diagnosis and Management of Viral Respiratory Infections
Sammanfattning : Acute respiratory tract infections (ARTIs), are the most common infections in man, and represent a major global health burden. Viruses, most often causing a mild and self-limiting disease, yet with substantial morbidity and high costs for society, mainly cause upper respiratory tract infections. LÄS MER
4. Severe viral respiratory tract infections in children
Sammanfattning : Respiratory tract infections (RTIs) are estimated to cause 703.000 deaths annually in children below five years. The majority of RTIs in children are caused by viruses, yet the number of antivirals approved for treatment of these infections is very limited. LÄS MER
5. Acute respiratory infections among children in the Democratic Republic of Congo - nasopharyngeal pathogens, antibiotic resistance and vaccination
Sammanfattning : ABSTRACT Acute Lower Respiratory Infections (ALRI) remain a leading cause of morbidity and mortality among children in the Democratic Republic of the Congo (DR Congo). The pneumococcal conjugate vaccine PCV13 was introduced in the in the South-Kivu region in 2013. LÄS MER